Business
Why the Cyclopharm (ASX:CYC) share price popped 6% today
The Cyclopharm Limited (ASX: CYC) share price was sent soaring today after the company announced a business update.
Cyclopharm shares went as high as 14.41% in afternoon trade before closing 6.78% up at $2.52 per share.
What Cyclopharm does
Cyclopharm is an ASX-listed radiopharmaceutical company headquartered in New South Wales. It currently has a market capitalisation of just over $203 million.
As stated on the company’s website, “the company’s mission is to provide nuclear medicine and other clinicians with the ability to improve patient care outcomes.”
The health company aims to achieve this objective through the provision of its core radiopharmaceutical product, Technegas, which is used in functional lung ventilation…
-
General17 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
General23 hours agoTeam Australia wins back-to-back Motocross of Nations titles
-
Noosa News23 hours agoYork family honours late son with tractor museum to fund cancer research
-
Noosa News19 hours agoPerth Royal Show attendance slumps to 10-year low